AmerisourceBergen main figures in T-Advisor

Market opportunities by T-Advisor: AmerisourceBergen

Market Opportunities

, No hay comentarios

T-Advisor, through its tool Market Opportunities, has detected the company AmerisourceBergen, listed in New York Stock Exchange (NYSE) as an opportunity for investment. These are the main figures about performances and volatility in the last years: AmerisourceBergen main figures in T-Advisor The chart shows the evolution in the last year:

AmerisourceBergen chart in T-Advisor

The technical analysis reveals also more data: AmerisourceBergen technical analysis in T-Advisor Finally, the risk analysis is as follows: AmerisourceBergen risk analysis in T-Advisor AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel. Company revenues increased last fiscal year 12.6%, till US$ 87,959 million, after a slight decrease the former year. This figures have to do with the strategic alliance with the German company Walgreens and Alliance Boots GmbH. However, net income dropped a 39,6%, till US$ 493,4 million. Share price have increased steadily and doubled the value since the beginning of 2012.  

Se el primero en escribir un comentario.

Escribir un comentario: